LT3200817T - Būdas ir kompozicija, skirti sustiprintų priešuždegiminių/antikatabolinių ir regeneracinių agentų gamybai iš autologinio kraujo - Google Patents

Būdas ir kompozicija, skirti sustiprintų priešuždegiminių/antikatabolinių ir regeneracinių agentų gamybai iš autologinio kraujo

Info

Publication number
LT3200817T
LT3200817T LTEPPCT/CA2015/000521T LT15847588T LT3200817T LT 3200817 T LT3200817 T LT 3200817T LT 15847588 T LT15847588 T LT 15847588T LT 3200817 T LT3200817 T LT 3200817T
Authority
LT
Lithuania
Prior art keywords
anticatabolic
inflammatory
composition
production
enhanced anti
Prior art date
Application number
LTEPPCT/CA2015/000521T
Other languages
English (en)
Inventor
Anthony Galea
Irina Brokhman
Original Assignee
Antnor Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antnor Limited filed Critical Antnor Limited
Publication of LT3200817T publication Critical patent/LT3200817T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
LTEPPCT/CA2015/000521T 2014-09-30 2015-09-30 Būdas ir kompozicija, skirti sustiprintų priešuždegiminių/antikatabolinių ir regeneracinių agentų gamybai iš autologinio kraujo LT3200817T (lt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CA2866480A CA2866480A1 (en) 2014-09-30 2014-09-30 Method and composition for producing enhanced anti-inflammatory and regenerative agents from autologous physiological fluid
CA2891445A CA2891445A1 (en) 2014-09-30 2015-05-14 Method and composition for producing enhanced anti-inflammatory/anti-catabolic and regenerative agents from autologous physiological fluid
CA2900537A CA2900537A1 (en) 2014-09-30 2015-08-13 Method and composition for producing enhanced anti-inflammatory/anti-catabolic and regenerative agents from autologous physiological fluid
PCT/CA2015/000521 WO2016049746A1 (en) 2014-09-30 2015-09-30 Method and composition for producing enhanced anti-inflammatory/ anti-catabolic and regenerative agents from autologous physiological fluid

Publications (1)

Publication Number Publication Date
LT3200817T true LT3200817T (lt) 2022-08-10

Family

ID=55590205

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/CA2015/000521T LT3200817T (lt) 2014-09-30 2015-09-30 Būdas ir kompozicija, skirti sustiprintų priešuždegiminių/antikatabolinių ir regeneracinių agentų gamybai iš autologinio kraujo

Country Status (15)

Country Link
US (3) US10532072B2 (lt)
EP (1) EP3200817B1 (lt)
JP (1) JP6646660B2 (lt)
KR (1) KR102455394B1 (lt)
CN (1) CN107073083B (lt)
AU (1) AU2015327723B2 (lt)
CA (4) CA2866480A1 (lt)
CL (1) CL2017000670A1 (lt)
ES (1) ES2912773T3 (lt)
GB (1) GB2546224C (lt)
IL (1) IL251082B (lt)
LT (1) LT3200817T (lt)
MX (1) MX388111B (lt)
RU (1) RU2708242C2 (lt)
WO (1) WO2016049746A1 (lt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2866480A1 (en) 2014-09-30 2016-03-30 Antnor Limited Method and composition for producing enhanced anti-inflammatory and regenerative agents from autologous physiological fluid
CA2950659A1 (en) * 2016-12-06 2018-06-06 Antnor Limited Method for the preparation and prolonged storage of growth factors and cytokines obtained from platelet rich plasma
EP3613424A1 (en) * 2018-08-23 2020-02-26 Orthogen AG Novel methods for the production of pharmaceutical agents
WO2020243807A1 (en) * 2019-06-05 2020-12-10 Antnor Limited Method and composition for producing enhanced anti-inflammatory/anti-catabolic and regenerative agents from autologous physiological fluid
RU2747589C1 (ru) * 2019-12-09 2021-05-11 Руслан Яверович Атлуханов Способ лечения повреждения мениска коленного сустава
CA3076046A1 (en) * 2020-03-17 2021-09-17 Antnor Limited Method for producing enhanced anti-inflammatory/anti-catabolic agents from autologous physiological fluid with shortened incubation time
CA3106197A1 (en) * 2021-01-20 2022-07-20 Antnor Limited Method for producing blood plasma product useful in the treatment of viral infections characterized by an uncontrolled release of proinflammatory cytokines
JP7025070B1 (ja) * 2021-05-14 2022-02-24 セルソース株式会社 血液由来成長因子含有組成物及びその調製方法
JP7175055B1 (ja) 2021-05-14 2022-11-18 セルソース株式会社 血液由来成長因子含有組成物及びその調製方法
CN114146096B (zh) * 2021-11-25 2024-04-02 成都清科生物科技有限公司 一种富含细胞因子的条件血清的制备方法及应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0744892B1 (en) 1994-12-16 2003-12-03 Baxter International Inc. Anticoagulant compositions for platelets
DE19903876B4 (de) * 1999-02-01 2006-09-28 Orthogen Gentechnologie Gmbh Verfahren zur in-vitro-Bildung und Anreicherung von Interleukin-1 Rezeptor-Antagonisten
US20030166069A1 (en) 2000-11-28 2003-09-04 Amgen, Inc. Interleukin-1 receptor antagonist-like molecules and uses thereof
US20060177515A1 (en) 2005-02-09 2006-08-10 Reinhold Schmieding Method of producing autogenous or allogenic blood serum and related logistics
GB0700940D0 (en) 2007-01-18 2007-02-28 Univ Newcastle Reverse shoulder prosthesis
PL2259774T3 (pl) 2008-02-27 2013-04-30 Biomet Biologics Llc Sposoby i kompozycje dla wprowadzania antagonisty receptora interleukiny-1
US8460227B2 (en) * 2008-11-17 2013-06-11 Arthrex, Inc. Cytokine concentration system
EP2470162B1 (en) 2009-08-27 2019-03-27 Biomet Biologics, LLC Implantable device for production of interleukin-1 receptor antagonist
KR20140003398A (ko) 2010-09-03 2014-01-09 바이오멧 바이오로직스, 엘엘씨 인터루킨-1 수용체 길항제를 전달하는 방법 및 조성물
KR101313755B1 (ko) * 2010-12-09 2013-10-01 이선민 상피조직 또는 피하조직 재생용 자가혈장의 제조방법 및 이를 함유하는 조성물
US10167310B2 (en) 2012-01-31 2019-01-01 Estar Technologies Ltd System and method for producing interleukin receptor antagonist (IRA)
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9878011B2 (en) 2013-03-15 2018-01-30 Biomet Biologics, Llc Treatment of inflammatory respiratory disease using biological solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
CA2866480A1 (en) 2014-09-30 2016-03-30 Antnor Limited Method and composition for producing enhanced anti-inflammatory and regenerative agents from autologous physiological fluid

Also Published As

Publication number Publication date
CA2962289C (en) 2021-01-19
GB2546224C (en) 2025-04-09
RU2017114523A (ru) 2018-11-07
MX2017004131A (es) 2017-06-19
AU2015327723A1 (en) 2017-04-13
IL251082B (en) 2020-03-31
RU2017114523A3 (lt) 2019-05-06
US20240277760A1 (en) 2024-08-22
CA2962289A1 (en) 2016-04-07
RU2708242C2 (ru) 2019-12-05
CA2891445A1 (en) 2016-03-30
CN107073083B (zh) 2021-07-06
CL2017000670A1 (es) 2017-11-10
BR112017006410A2 (pt) 2017-12-19
CN107073083A (zh) 2017-08-18
EP3200817B1 (en) 2022-03-02
US12023352B2 (en) 2024-07-02
EP3200817A4 (en) 2018-06-20
EP3200817A1 (en) 2017-08-09
US20170296583A1 (en) 2017-10-19
IL251082A0 (en) 2017-04-30
WO2016049746A1 (en) 2016-04-07
CA2866480A1 (en) 2016-03-30
JP6646660B2 (ja) 2020-02-14
KR102455394B1 (ko) 2022-10-17
GB2546224B (en) 2020-04-22
GB201706803D0 (en) 2017-06-14
CA2900537A1 (en) 2016-03-30
US20200163991A1 (en) 2020-05-28
GB2546224A (en) 2017-07-12
ES2912773T3 (es) 2022-05-27
US10532072B2 (en) 2020-01-14
MX388111B (es) 2025-03-19
AU2015327723B2 (en) 2020-10-22
KR20170063836A (ko) 2017-06-08
JP2017533896A (ja) 2017-11-16

Similar Documents

Publication Publication Date Title
LT3206497T (lt) Kompozicijos ir būdai, skirti meibomo liaukos disfunkcijos gydymui
LT3204413T (lt) Nešiklio ir antikūno kompozicija, ir jos gamybos bei naudojimo būdai
LT3200817T (lt) Būdas ir kompozicija, skirti sustiprintų priešuždegiminių/antikatabolinių ir regeneracinių agentų gamybai iš autologinio kraujo
LT3224269T (lt) Kompozicijos ir būdai, skirti cns sutrikimams gydyti
LT3594238T (lt) Antikūno kompozicijos, skirtos navikų gydymui
HUE059158T2 (hu) Eljárás pridopidin elõállítására
LT3169328T (lt) Chinolino dariniai, skirti uždegiminių ligų gydymui
HUE064612T2 (hu) Eljárás brivaracetam elõállítására
DK3240612T3 (da) Fremgangsmåder til behandling af nethindesygdomme
LT3200815T (lt) Būdai ir kompozicijos, skirti vėžio gydymui
LT3390390T (lt) Bipirazolilo dariniai, tinkami naudoti autoimuninių ligų gydymui
PL3142785T3 (pl) Sposób wytwarzania alkenoli i ich zastosowanie do wytwarzania 1,3- butadienu
HUE050974T2 (hu) Eljárás pirimidinszulfamid-származékok elõállítására
HUE049170T2 (hu) Eljárás szubsztituált cikloszerinek elõállítására
SI3393976T1 (sl) Postopek proizvodnje titanovega oksida
PL3250042T3 (pl) Kompozycja, sposób, zastosowanie i wyrób
DK3578179T3 (da) Process for the preparation of cyclic depsipeptides
HUE059378T2 (hu) Szigetelõfólia, valamint szigetelõfólia elõállítására szolgáló eljárás
HUE063820T2 (hu) Módszerek kardiovaszkuláris betegségek kezelésére
BR112016015712A8 (pt) método de tratamento de doenças hepáticas.
LT3119386T (lt) Kompozicija, skirta panaudoti su tarpslanksteliniais diskais susijusio skausmo gydymui
IL252707A0 (en) Compositions and methods for treating diseases and conditions
LT3244889T (lt) Farmacinė kompozicija, skirta mikozės gydymui
PL3903774T3 (pl) N,n-bis-2-merkaptoetyloizoftalamid do leczenia chorób neurodegeneracyjnych
DK3393583T3 (da) Opløslig glycoprotein til behandling af trombotiske sygdomme